Nkarta, Inc. (NKTX) stock
NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.10 (-8.00%)
Close on Nov 18, 2026Market cap $82.37MP/E –Yield 0.00%
Nkarta operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nkarta's operating cash flow for the twelve months ending Jun 30, 2026 was -$92.76M. For fiscal 2025 it was -$88.70M. The highest annual figure on record is -$18.37M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$88.70M | – |
| FY2024 | Dec 31, 2024 | -$99.70M | – |
| FY2023 | Dec 31, 2023 | -$86.16M | – |
| FY2022 | Dec 31, 2022 | -$57.00M | – |
| FY2021 | Dec 31, 2021 | -$67.93M | – |
| FY2020 | Dec 31, 2020 | -$43.51M | – |
| FY2019 | Dec 31, 2019 | -$18.37M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$24.22M | – |
| Q1 FY2026 | Mar 31, 2026 | -$28.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$21.65M | – |
| Q3 FY2025 | Sep 30, 2025 | -$18.69M | – |
| Q2 FY2025 | Jun 30, 2025 | -$18.75M | – |
| Q1 FY2025 | Mar 31, 2025 | -$29.61M | – |
| Q4 FY2024 | Dec 31, 2024 | -$24.75M | – |
| Q3 FY2024 | Sep 30, 2024 | -$24.55M | – |
| Q2 FY2024 | Jun 30, 2024 | -$21.89M | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.51M | – |
| Q4 FY2023 | Dec 31, 2023 | -$23.35M | – |
| Q3 FY2023 | Sep 30, 2023 | -$20.28M | – |
| Q2 FY2023 | Jun 30, 2023 | -$21.77M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.76M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.33M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.80M | – |
| Q2 FY2022 | Jun 30, 2022 | -$16.61M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.26M | – |
| Q4 FY2021 | Dec 31, 2021 | -$17.57M | – |
| Q3 FY2021 | Sep 30, 2021 | -$18.26M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.45M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.65M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.85M | – |
| Q3 FY2020 | Sep 30, 2020 | -$12.12M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.24M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.29M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.64M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.65M | – |
See a number that looks wrong?